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Abstract
Background: Though screening and intervention for alcohol and tobacco misuse are effective, primary care
screening and intervention rates remain low. Previous studies have increased intervention rates using vital signs
screening for tobacco misuse and clinician prompts for screen-positive patients for both alcohol and tobacco
misuse. This pilot study’s aims were: (1) To determine the feasibility of combined vital signs screening for tobacco
and alcohol misuse, (2) To assess the impact of vital signs screening on alcohol and tobacco screening and
intervention rates, and (3) To assess the additional impact of tobacco assessment prompts on intervention rates.
Methods: In five outpatient practices, nurses measuring vital signs were trained to routinely ask a single tobacco
question, a prescreening question that identified current drinkers, and the single alcohol screening question for
current drinkers. After 4-8 weeks, clinicians were trained in tobacco intervention and nurses were trained to give
tobacco abusers a tobacco questionnaire which also served as a clinician intervention prompt. Screening and
intervention rates were measured using patient exit interviews (n = 622) at baseline, during the “screening only”
period, and during the tobacco prompting phase. Changes in screening and intervention rates were compared
using chi square analyses and test of linear trends. Clinic staff were interviewed regarding patient and staff
acceptability. Logistic regression was used to evaluate the impact of nurse screening on clinician intervention, the
impact of alcohol intervention on concurrent tobacco intervention, and the impact of tobacco intervention on
concurrent alcohol intervention.
Results: Alcohol and tobacco screening rates and alcohol intervention rates increased after implementing vital
signs screening (p < .05). During the tobacco prompting phase, clinician intervention rates increased significantly
for both alcohol (12.4%, p < .001) and tobacco (47.4%, p = .042). Screening by nurses was associated with clinician
advice to reduce alcohol use (OR 13.1; 95% CI 6.2-27.6) and tobacco use (OR 2.6; 95% CI 1.3-5.2). Acceptability was
high with nurses and patients.
Conclusions: Vital signs screening can be incorporated in primary care and increases alcohol screening and
intervention rates. Tobacco assessment prompts increase both alcohol and tobacco interventions. These simple
interventions show promise for dissemination in primary care settings.
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One in three adults worldwide is a regular smoker, and
among these adults, 50% will die from cigarettes [1].
Cigarette smoking is the most important source of pre-
ventable morbidity and mortality in the US, with cost
exceeding $167 billion annually [2]. Almost 30% of pri-
mary care patients use some form of tobacco [3].
Alcohol use is related to a wide range of harms [4].
Approximately one-third of all US adults are involved in
alcohol misuse [5], including 14 million adults with
alcohol abuse or alcoholism and almost twice that num-
ber who are involved in at-risk drinking (for women,
more than three drinks per day or seven drinks per
week and for men, more than four drinks per day or 14
drinks per week). The cost of alcohol misuse in the U.S.
is approximately $140 billion annually [6]. Among pri-
mary health care patients,7t o2 0p e r c e n te n g a g ei n
alcohol misuse [7]. Alcohol use and tobacco use are
often associated, with approximately 50% of alcohol
misusers concurrently using tobacco [8,9]. Concurrent
tobacco and alcohol use synergistically increase the risk
of head and neck and esophageal cancer [10,11]. Binge
drinking and alcohol abuse also hinder individuals’
efforts to stop smoking [12-14].
Primary care intervention for alcohol and tobacco
misuse is effective and reduces morbidity and mortality.
Brief advice by primary care clinicians increases quit
rates for smokers [15,16]and helps hazardous and harm-
ful drinkers decrease their alcohol consumption [17].
Smoking cessation significantly reduces future cancer
risk [18-22]. The U.S. Preventive Services Task Force
now recommends screening and office intervention for
both tobacco use and problem drinking [23,24]. Com-
bined tobacco and alcohol intervention has the potential
to reduce tobacco- and alcohol-related morbidity and
cancer risk. Nonetheless, tobacco and alcohol screening
and intervention are not consistently performed in most
primary care practices. Despite education and training
initiatives in alcohol [25-27] and tobacco [1,8,28-30],
health care providers screen only 28% of patients for
alcohol misuse [31] and 48% for tobacco abuse
[1,28,32,33].
In an effort to increase screening rates, office proto-
cols have been developed to screen patients before they
see their clinicians and prompt clinicians to intervene
when screens are positive. Using a vital signs stamp that
assesses smoking status as part of nursing vital signs has
been shown to increase tobacco cessation rates in three
of four studies [34-37]. For alcohol screening, a vali-
dated single alcohol screening question (SASQ: “When
was the last time you had more than X drinks in one
day?” where X = 4 for women and 5 for men) has
demonstrated acceptable sensitivity and specificity
[8,38,39], however no previous studies have attempted
to include this question in nursing vital signs.
Most studies employing reminder systems which
prompt primary care clinicians to intervene have resulted
in increased clinician intervention rates for tobacco
abuse [40-42] and alcohol misuse [43-45], though some
studies have showed mixed results [27]. A study by Milch
et al [32] combined vital signs screening with nurse
administration of a brief tobacco assessment instrument
which was then used as a clinician prompt, resulting in
increased tobacco interventions by clinicians and higher
rates of self-reported smoking cessation. Findings from
this single study, however, have not yet been replicated.
The purposes of this multi-site study were to: (1) deter-
mine the feasibility of combined vital signs screening for
tobacco and alcohol misuse, (2) assess the impact of vital
signs screening alone on alcohol and tobacco screening
and intervention rates, and (3) assess the impact of com-
bined vital signs screening plus use of a tobacco prompt
for increasing tobacco interventions.
Methods
Study Site Recruitment
This study was approved by the Institutional Review
Board of the Medical Center of Central Georgia in
Macon, GA, and was conducted from July 2004 to July
2005. A total of 625 patients were eligible and consented
to participate in this study.
Interviews were conducted at five Central Georgia
family physician offices within the Georgia-Mercer Pri-
mary Care Research Network. All clinicians at these
offices (physicians, nurse practitioners, and physician
assistants) were chosen because of their participation in
previous research network studies and were recruited by
personal interview. Participation rate was 100% (no refu-
sals). All five were single specialty offices, and two
offices had physician extenders (one nurse practitioner
and one physician assistant). Typical of family physi-
cians, all five clinician offices treat the full range of
patients: infants to the elderly, with a wide range of pro-
blems. The number of patient visits per day ranged
from 20 to 60 per clinician. There was a mix of fee for
service, HMO, PPO, Medicare and Medicaid patients at
each office.
Study Design
This was a pre-post intervention study conducted in
three phases of approximately 50 days each. Prior to
integrating alcohol and tobacco vital signs screening
into the clinic protocol, baseline alcohol and tobacco
screening and intervention rates were collected in Phase
I. The effect of each of the study’s two interventions
was measured in phases II and III. Vital signs screening
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signs screening plus the tobacco prompt in Phase III.
Changes in the following variables were assessed across
the study’s three phases: alcohol screening by nurses,
alcohol screening by clinicians, alcohol screening by
nurses and/or clinicians, clinician alcohol intervention,
tobacco screening by nurses, tobacco screening by clini-
cians, tobacco screening by nurses and/or clinicians, and
clinician tobacco interventions. For patients reporting
tobacco interventions, we also measured the frequency
with which clinicians performed any of the seven steps
listed on the tobacco intervention prompt (see Figure 1).
In each phase, approximately 40 patients per practice
completed exit interviews. Prior to baseline measure-
ment, clinicians were informed that the study would
involve testing simple interventions that nurses might
Figure 1 Tobacco Assessment Questionnaire.
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tobacco and alcohol screening and intervention. Clini-
cians were not informed in advance of patient interview
days but were often aware when the interviewer was
present. In Phase II, which assessed the impact of
including alcohol and tobacco screening questions in
the nursing vital signs, screening was performed using
three questions. The first assessed tobacco use. The sec-
ond question ("Have you had more than six alcoholic
drinks in the past year?”)i d e n t i f i e dp a t i e n t sw h ow e r e
current drinkers. The third question, the SASQ was
administered only to patients identified as current drin-
kers. A vital signs “stamp” was created which could be
used to stamp these three questions onto the vital signs
portion of the patient’s chart (see Figure 2). A fifteen-
minute orientation session was conducted to orient clin-
icians to the project procedures and train nurses to ask
the three questions as part of nursing vital signs. Proce-
dures were modified for two clinics with electronic med-
ical records which used templates that could not easily
be modified to include the screening questions as part
of nursing vital signs. In one clinic, the screening ques-
tions were printed on sheets of paper and placed in
each examining room on clipboards. Nurses were
instructed to ask the questions when they placed
patients in the room. In the other clinic, the questions
were stamped on the paper where nurses routinely
recorded each patient’s vital signs and left them in the
exam room for the physician. Clinicians were informed
that positive screens included any tobacco use or drink-
i n gm o r et h a nf o u r( f o rf e m a l e s )o rf i v ed r i n k s( f o r
males) on any day in the past three months, and were
encouraged to talk with patients about modifying these
habits. In Phase III, vital signs screening continued, and
nurses were asked to give a tobacco assessment instru-
ment, adapted from Milch et al [32], to all patients
reporting tobacco use (see Figure 1), ask them to
complete it and give it to their clinician. All clinicians
also received one hour of tobacco intervention training
using the steps of the Agency for Healthcare Research
and Quality’s Clinician’s Guide [46]. No specific training
was provided regarding further alcohol assessment or
brief intervention.
The feasibility of vital signs screening was assessed by
interviewing nurses and clinicians and by observation of
nurses and clinician behavior by two project investiga-
tors (JPS and MG) during Phases II and III at each
clinic. The impact of the Phase II and III interventions
on alcohol screening and intervention rates was assessed
via patient exit interviews.
Patient Recruitment and Eligibility Criteria
In order to monitor clinic screening and intervention
rates, patients were recruited in clinic waiting areas and
written informed consent was obtained. Each male
patient and every other female patient was invited to
participate. Patients first completed a four-question
written health habits questionnaire regarding weight,
consumption of saturated fats, tobacco use, and alcohol
use. English-speaking patients who had consumed at
least six alcoholic drinks in the past year and had not
already been interviewed for this study met inclusion
criteria for the study and were asked to return for an
interview after seeing their primary care clinician.
Measures
The exit interview included demographic information
including ethnicity, which was recorded based on
patients’ self-report. The interview also included the
Diagnostic Interview Schedule for alcohol use disorders
[47] and a 29-day alcohol Timeline Followback Inter-
view [48]. Alcohol screening was defined as an affirma-
tive answer to the question, “Today, did the nurse who
took your blood pressure ask you about your alcohol
Figure 2 Health Habits Stamp for Vital Signs Screening.
Seale et al. BMC Family Practice 2010, 11:18
http://www.biomedcentral.com/1471-2296/11/18
Page 4 of 9use?” Alcohol intervention was defined as an affirmative
answer to the question, “Today, did the doctor discuss
cutting down or stopping your alcohol use?” Similarly
worded questions were used to define tobacco use and
intervention. Patients who reported being advised to
reduce their tobacco use were asked whether the clini-
c i a nh a de n c o u r a g e dt h e mt os e taq u i td a t e ,d i s c u s s e d
possible use of pharmacotherapy, given them a smoking
cessation handout, or given them information regarding
tobacco cessation programs or telephone counseling
services.
To determine the percentage of patients who should
receive an intervention we calculated the prevalence of
alcohol misuse and tobacco abuse using exit interview
responses. Alcohol misuse was defined as presence of a
DSM-IV [49] alcohol use disorder or at-risk drinking,
defined using NIAAA criteria of more than three drinks
in a day or seven drinks in a week for women and more
than four drinks in a day or 14 drinks in a week for
men [50]. Tobacco abuse was defined as any self-
reported tobacco use. All patients with alcohol misuse
or tobacco abuse were considered as appropriate
patients for clinician interventions.
Statistical Analyses
Statistical programs that are available in SPSS for Win-
dows (version 14.0) were used for analysis [51]. Ethnic
differences in age stratified by gender were determined
using independent t-tests. Ethnic specific rates for alco-
hol misuse and tobacco abuse were also stratified by
gender, and differences in rates were determined using
chi-square tests. Changes in screening and intervention
rates across study phases were determined using tests of
linear trends. Pair differences in screening rates between
individual study phases were measured using chi-square
tests.
To assess the odds of alcohol and tobacco interven-
tions that were associated with nurse screening (inde-
pendent variable), we fitted both univariate and
multivariate logistic regression models using alcohol
intervention and tobacco intervention as dependent vari-
ables. We compared odds ratios of alcohol intervention
and tobacco intervention that were associated with
nurse screening as part of vital signs. To investigate
whether offering tobacco advice was associated with
offering alcohol advice and vice versa, we also fitted uni-
variate and multivariate logistic regression models in
which first alcohol advice, then tobacco advice was used
as the dependent variable. In all multivariate analyses,
statistical adjustments were made for patient age, gender
and ethnicity. The customary p-values of < 0.05 and
95% confidence intervals were used to indicate statistical
significance.
Results
Vital signs screening was successfully implemented dur-
ing a two-month period at all clinics. Although some
nursing staff expressed concerns about asking all
patients about the sensitive subject of alcohol prior to
startup, these concerns dissipated during the first week
as they quickly adapted to talking with patients about
their tobacco and alcohol use. After implementation,
nurses reported that patients readily accepted the vital
signs screening as a part of their visit and that most
answered questions freely, with few questions or objec-
tions. Two clinics with electronic medical records were
unable to insert the alcohol and drug questions into
their vital signs templates and collected this information
using paper sheets. This was problematic in one clinic,
as this created a new procedure which required nurses
to remember to pick up a clipboard and ask the screen-
ing questions. In the other clinic, fewer problems were
experienced: the receptionist stamped the vital signs
questions onto the paper where nurses routinely
recorded vital signs, thereby integrating the new ques-
tions into the existing vital signs procedure.
A total of 622 patients (99.5% of patients who con-
sented to participate) provided complete answers to all
questions. Approximately 120 patients were recruited
from each of the participating five primary care prac-
tices. Subject refusal rate, measured during the final
month of the study, was 17.5%.
Of the study participants, 378 (60.7%) were white and
238 (38.2%) were African American. Six (1%) were of
other races. Mean (SD) age was 40.4 (12.8) years (med-
ian = 40) for women and 42.1 (13.7) years (median =
41) for men. Age and gender distribution of subjects is
shown in Table 1. Among men, more whites than Afri-
can Americans met diagnostic criteria for alcohol mis-
use (p < .05), however tobacco abuse rates showed no
significant differences. There were no statistically signifi-
cant ethnic differences in rates of alcohol misuse or
tobacco abuse among women.
Low rates of alcohol screening were reported during
the baseline period for both nurses alone and for nurses
and clinicians combined (9.5 and 14.7% of patients,
respectively; see Table 2). Both these rates increased sig-
nificantly after implementing vital signs screening
(38.1% and 40.5%, respectively) in Phase II, then pla-
teaued in Phase III, with overall screening rates remain-
ing near 40%. Alcohol screening and alcohol
intervention by clinicians increased modestly but signifi-
cantly across all phases (p < .001). Changes in tobacco
screening rates followed a similar pattern to those
observed with alcohol. Tobacco screening rates for
nurses alone and for nurses and clinicians combined
increased significantly from baseline (20.4% and 28.0%,
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then plateaued, with overall screening rates remaining
near 50%. Interestingly, tobacco intervention rates by
clinicians ("clinician advice to quit”) showed no increase
after implementation of vital signs screening alone
(Phase II), then increased significantly with the addition
of clinician prompting in Phase III to 47.4% (p = .042).
Statistical analysis also revealed significant increases
across study phases in three individual quit steps (asking
patients what would motivate them to quit, giving
pamphlets, and discussions about quit dates) and highly
significant increases in two steps: discussing quit medi-
cations and prescribing quit medications.
Logistic regression analysis demonstrated that nurse
screening significantly increased the odds of alcohol
intervention, both before adjusting for sociodemographic
variables (odds ratio [OR] 12.9, 95% CI: 6.3 - 26.7) and
after adjusting (OR 13.1, 95% CI 6.2-27.6). Nurse
screening also significantly improved the odds of
tobacco intervention both before (OR 2.1, 95% CI 1.1-
5.9) and after adjusting for demographic variables (OR
2.6, 95% CI: 1.3 - 5.2). Giving tobacco advice was asso-
ciated with increased odds of giving alcohol advice in
both univariate (OR 6.8, 95% CI 2.56-17.8) and multi-
variate (OR 7.4; 95% CI 2.8-20.1) analyses. Similarly,
giving alcohol advice was also associated with increased
Table 2 Changes in Alcohol and Tobacco Screening and Intervention Rates by Study Phases (%)
Phase I Phase II Phase III p
(n = 211) (n = 210) (n = 201)
Alcohol Screening and Intervention Rates
Screening by Nurses 9.5
a 38.1
b 32.3
c .018
Screening by Clinicians 9.5
a 13.4
b 21.9
c <.001
Any Screening (Nurses or Clinicians) 14.7
a 40.5
b 37.8
c .041
Clinician Alcohol Interventions 3.8
a 6.7
b 12.4
c <.001
Tobacco Screening Rates
Screening by Nurses 20.4
a 44.8
b 41.3
c .081
Screening by Clinicians 18.5 18.1 26.0 .121
Any Screening (Nurses or Clinicians) 28.0
a 49.5
b 49.0
b .371
Tobacco Intervention Rates (n = 87) (n = 76) (n = 76)
Clinician advice to quit 32.2
a 30.3
b 47.4
c .042
Specific Tobacco Quit Steps
Asked what would motivate patient to quit 14.3 17.6 25.0 .021
Gave patient a pamphlet 9.1 9.5 15.4 .017
Discussed lessons learned from past attempts 7.9 6.8 9.2 .421
Discussed setting a date to quit 3.9 8.1 10.8 .029
Discussed nicotine products or other meds 9.2
a 16.2
b 24.2
c <.001
Prescribed bupropion or a nicotine product 3.9
a 5.4
b 12.1
c <.001
Gave info about Tobacco Quit Line 5.3 1.4 6.1 .711
Referred to a smoking cessation program 2.6 2.7 3.0 .052
Values with different superscripts differ from each other at p < .05 on pairwise comparison; p-values listed in the table arefrom test of linear trends across study
phases
Table 1 Characteristics of Study Population
Men Women
White Black p White Black p
(n = 189) (n = 92) (n = 189) (n = 146)
Age, in years
Mean (SD) 42.7 (14.3) 41.0 (12.6) .388 40.4 (13.5) 40.5 (11.8) .992
Median 42 41.5 40 41
Alcohol misuse 45.2% 31.5% .029 29.6% 30.8% .814
Tobacco abuse 41.8% 33.0% .156 39.2% 37.7% .782
Notes: Alcohol misuse is defined as at-risk drinking (consumption of more than 3 drinks in 1 day or 7 in 1 week for women, and more than 4 in 1 day or 14 in 1
week for men) and/or presence of a DSM-4 alcohol-use disorder (alcohol abuse and/or alcohol dependence).
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CI 3.14-15.15) and after adjusting for age, gender and
ethnicity (OR 7.47: 95% CI 3.32-16.79).
Discussion
Previous primary care studies have used health screen-
ing surveys to assess alcohol and tobacco use [52-54],
but the current study is one of the first to incorporate
screening for both alcohol and tobacco as part of the
vital signs. Screening was accomplished using the SASQ
[39], which was easily included in the brief nursing
encounter used for vital signs measurement. The three-
question screening system designed for this study
proved to be acceptable to nurses, clinicians and
patients and resulted in significant increases in alcohol
and tobacco screening. Although universal screening
was not achieved, alcohol screening rates were similar
to the 44-50% range seen in previous multi-site studies
designed to increase alcohol screening in primary care
[44,45,55]. Results from Phase II of this study demon-
strated modest but significant increases in clinician
interventions for alcohol but not for tobacco from vital
signs screening alone. Our findings are similar to those
of Piper et al [37], who found no increase in tobacco
intervention rates from vital signs screening for tobacco
alone.
This study’sm o r ei n t e n s i v ei n t e r v ention, the addition
of a previously-studied tobacco assessment instrument
which was also used as a clinician prompt, further
improved rates of clinician tobacco cessation advice.
Clinician prompts have previously been shown to
increase clinician interventions with other health habits
such as alcohol misuse [44,45]. Our study confirms pre-
vious findings of Milch et al [32] regarding the effective-
ness of a tobacco prompt in increasing tobacco
intervention rates. In this study, clinician cessation
advice rates attained with use of the prompt (47%) were
equal to those found in Milch’s study. There were also
significant increases in multiple tobacco cessation coun-
seling steps advocated in the steps of the Agency for
Healthcare Research and Quality’s Clinician’s Guide [46]
such as setting a quit date and exploring patients’ moti-
vation for quitting, indicating that clinicians went
beyond simple brief advice. The most significant
increases were seen in clinicians’ discussing and pre-
scribing quit products, which have been proven to
increase patient abstinence rates [56].
This study addresses an important current need in
primary care: the development of efficient methods for
addressing multiple health risk behaviors in a single visit
[57,58]. Existing research indicates that physicians limit
the preventive services they offer due to time constraints
and the high number of competing demands encoun-
tered during a single office visit [59,60]. Physicians also
report a lack of confidence in their ability to screen and
provide brief advice [61]. A somewhat surprising finding
of this study was the fact that vital signs screening for
both tobacco and alcohol misuse, followed by clinician
prompts for tobacco abuse only, resulted in increases in
both alcohol and tobacco interventions. Despite the
time constraints, clinicians in this study who dedicated
time to tobacco assessment and counseling were also
more likely to perform alcohol interventions. This find-
ing suggests that clinicians providing advice to change
one lifestyle behavior may find it easier to address a sec-
ond behavior. Starting with tobacco use as the target
behavior might also increase the physician’sc o n f i d e n c e
in providing screening and advice for alcohol misuse.
Further study is needed to explore the link between
advice for these two behaviors and perhaps better utilize
tobacco cessation encounters as an opportunity to
increase clinician alcohol intervention rates.
Limitations
This study, performed in five single physician practices
in the southeastern U.S., may not be representative of
other areas of the U.S. However, two strengths of the
study are the ethnic diversity of the patient population
studied and the involvement of multiple practice sites.
Data regarding tobacco screening and intervention were
collected only on current drinkers and may not be
representative of all tobacco users. Lack of blinding phy-
sicians to the presence of the patient interviewer may
have influenced their clinical behavior. This study,
which was designed to assess practice change behavior,
did not assess the impact of clinician interventions on
patients’ subsequent alcohol and tobacco use or solicit
patient feedback regarding the vital sign screening
process.
Conclusions
This study demonstrates that vital signs screening is a
simple, efficient and well-accepted method for con-
ducting alcohol and tobacco screening in primary care,
and that this intervention, when combined with clini-
cian prompting, increases alcohol and tobacco screen-
ing and intervention rates. Importantly, the tobacco
assessment prompts in this study increased both alco-
hol and tobacco interventions. While this simple, low-
cost intervention resulted in modest but significant
increases, future research should explore interventions
which would further increase these rates. Techniques
which have been utilized in other studies include
emphasizing the link between alcohol misuse and bio-
medical consequences such as hypertension [62] or
abnormal laboratory tests [63], academic detailing [64],
and use of a more complex systems-based quality
improvement intervention approach [65]. Future
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tion, which has been shown to increase clinician confi-
dence in performing brief intervention [66-69], and
test use of a combined sheet with both tobacco and
alcohol brief advice steps, in order to improve transla-
tion of effective intervention strategies for alcohol and
tobacco in primary care.
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